Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?-Reference-Cited by-同舟云学术

Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?

Published:2024-01-08 Issue: Volume: Page:
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Contreras-Toledo Débora^ORCID,Jiménez-Fonseca Paula,López Carlos López,Montes Ana Fernández,López Muñoz Ana María,Vázquez Rivera Francisca,Alonso Vicente,Alcaide Julia^ORCID,Salvà Francesc,Covela Rúa Marta,Guillot Mónica,Martín Carnicero Alfonso,Jimeno Mate Raquel,Cameselle García Soledad,Asensio Martínez Elena,González Astorga Beatriz,Fernandez-Diaz Amaya B.,González Villaroel Paula,Virgili Manrique Anna C.,Melián Sosa Marcos,Alonso Beatriz,Cousillas Castiñeiras Antia,Castañón López Carmen,Aparicio Jorge,Carmona-Bayonas Alberto^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

https://www.nature.com/articles/s41416-023-02563-w.pdf

Reference50 articles.

1. Ottaiano A, Normanno N, Facchini S, Cassata A, Nappi A, Romano C, et al. Study of Ras mutations’ prognostic value in metastatic colorectal cancer: STORIA analysis. Cancers. 2020;12:1919.

2. Bylsma LC, Gillezeau C, Garawin TA, Kelsh MA, Fryzek JP, Sangaré L, et al. Prevalence of RAS and BRAF mutations in metastatic colorectal cancer patients by tumor sidedness: a systematic review and meta‐analysis. Cancer Med. 2020;9:1044–57.

3. Bazan V, Migliavacca M, Zanna I, Tubiolo C, Grassi N, Latteri MA, et al. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype. Ann Oncol. 2002;13:1438–46.

4. Zhu G, Pei L, Xia H, Tang Q, Bi F. Role of oncogenic KRAS in the prognosis, diagnosis and treatment of colorectal cancer. Mol Cancer. 2021;20:1–17.

5. Patelli G, Tosi F, Amatu A, Mauri G, Curaba A, Patane DA, et al. Strategies to tackle RAS-mutated metastatic colorectal cancer. ESMO Open. 2021;6:100156.